Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 7 Rectal Neoplasms 5 Nasopharyngeal Carcinoma 5 Colorectal Neoplasms 5 Uterine Cervical Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Recurrence 3 Pancreatic Neoplasms 3 Melanoma 3 Esophageal Squamous Cell Carcinoma 3 Carcinoma, Non-Small-Cell Lung 3 Carcinoma, Hepatocellular 3 Neoplasms 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Renal Cell 2 Advanced Solid Tumor 2 Triple Negative Breast Neoplasms 1 Squamous Cell Non-small Cell Lung Cancer 1 Solid Tumor, Adult 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Sarcoma 1 Salivary Gland Neoplasms 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Neuroblastoma 1 Neoplasms by Site 1

Interventions

Rituximab 39 Cyclophosphamide 35 Magnetic Resonance Spectroscopy 22 Specimen Handling 20 Doxorubicin 18 polatuzumab vedotin 17 Prednisone 17 Lenalidomide 15 Biopsy 15 fludarabine 13 Oxaliplatin 13 Gemcitabine 13 zanubrutinib 11 Vincristine 11 Immunotherapy, Adoptive 10 Etoposide 10 glofitamab 9 axicabtagene ciloleucel 7 Prednisolone 7 obinutuzumab 6 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 6 Leukapheresis 6 Injections 6 Ifosfamide 6 Bendamustine Hydrochloride 6 loncastuximab tesirine 5 ibrutinib 5 acalabrutinib 5 Carboplatin 5 CT-P10 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Lymphoma, Large B-Cell, Diffuse × spartalizumab × Clear all

NCT06758037 2025-03-18

HiR+X

First Affiliated Hospital of Ningbo University

Phase 2 Recruiting

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡